Erste Asset Management’s Sage Therapeutics SAGE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$261K	Hold	28,500	–	–	﹤0.01%	731
2025 Q1	$236K	Hold	28,500	–	–	﹤0.01%	467
2024 Q4	$158K	Hold	28,500	–	–	﹤0.01%	493
2024 Q3	$208K	Hold	28,500	–	–	﹤0.01%	481
2024 Q2	$305K	Hold	28,500	–	–	﹤0.01%	451
2024 Q1	$543K	Hold	28,500	–	–	0.01%	414
2023 Q4	$629K	Hold	28,500	–	–	0.01%	408
2023 Q3	$591K	Hold	28,500	–	–	0.01%	388
2023 Q2	$1.34M	Hold	28,500	–	–	0.02%	328
2023 Q1	$1.19M	Hold	28,500	–	–	0.02%	334
2022 Q4	$1.1M	Hold	28,500	–	–	0.02%	346
2022 Q3	$1.13M	Hold	28,500	–	–	0.03%	342
2022 Q2	$935K	Hold	28,500	–	–	0.02%	362
2022 Q1	$977K	Buy	28,500 +16,500	+138%	+$566K	0.02%	355
2021 Q4	$510K	Sell	12,000 -21,500	-64%	-$914K	0.01%	427
2021 Q3	$1.48M	Hold	33,500	–	–	0.03%	304
2021 Q2	$1.89M	Hold	33,500	–	–	0.04%	288
2021 Q1	$2.45M	Hold	33,500	–	–	0.06%	247
2020 Q4	$2.92M	Buy	33,500 +14,800	+79%	+$1.29M	0.08%	230
2020 Q3	$1.12M	Hold	18,700	–	–	0.04%	295
2020 Q2	$781K	Hold	18,700	–	–	0.03%	307
2020 Q1	$552K	Hold	18,700	–	–	0.03%	299
2019 Q4	$1.37M	Sell	18,700 -15,500	-45%	-$1.14M	0.06%	249
2019 Q3	$4.88M	Hold	34,200	–	–	0.26%	110
2019 Q2	$6.17M	Sell	34,200 -4,600	-12%	-$830K	0.33%	79
2019 Q1	$6.2M	Buy	38,800 +3,300	+9%	+$527K	0.35%	72
2018 Q4	$3.12M	Buy	+35,500	New	+$3.12M	0.21%	121